Non-invasive prenatal diagnosis of Down's syndrome

Lancet

Volumn 369, Issue 9578, 2007, Pages 1997-

  Lo, YM Dennis ^a   Chiu, Rossa WK ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FORMALDEHYDE; DIAGNOSTIC AGENT; FIXATIVE;

CLINICAL PRACTICE; DOWN SYNDROME; HUMAN; LETTER; MATERNAL PLASMA; NON INVASIVE PROCEDURE; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; FEMALE; GENETICS; MALE; METHODOLOGY; NOTE;

DNA; FEMALE; FIXATIVES; FORMALDEHYDE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRENATAL DIAGNOSIS;

EID: 34250201487     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60935-0     Document Type: Letter

References (4)

1. Dhallan R., Guo X., Emche S., et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 369 (2007) 474-481
2. Lo Y., and Chiu R. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 8 (2007) 71-77
3. Chinnapapagari S., Holzgreve W., Lapaire O., Zimmermann B., and Hahn S. Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. Clin Chem 51 (2005) 652-655
4. Chung G., Chiu R., Chan K., Lau T., Leung T., and Lo Y. Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. Clin Chem 51 (2005) 655-658